BioSpace News Archive

Gossamer Bio, Inc. announced that Sheila Gujrathi, M.D., Chief Executive Officer and Co-Founder, will participate in a fireside chat at the Bank of America Merrill Lynch Health Care Conference on Tuesday, May 14 at 1:00 p.m. PT.

Collaboration will broaden Tmunity’s pipeline to include a glioma T cell therapy engineered to express a newly discovered T cell receptor

Data From WATER, WATER II and Single-Center Studies of PROCEPT BioRobotics’ Aquablation Therapy Will Be Revealed

First-quarter revenue $2,684 million and Adjusted EBITDA $587 million

Additional Independent Recognition of DrJud Apps for Everyday Addictions

Top Agricultural Robot Categories Will Include Unmanned Aerial Vehicles, Driverless Tractors, Material Management Robots, Soil Management Robots, and Dairy Management Robots

Are patients being adequately protected when they are involved in studies of new medical therapies and devices?

Syros Pharmaceuticals (NASDAQ: SYRS), a leader in the development of medicines that control the expression of genes, today reported financial results for the quarter ended March 31, 2019 and provided an update on recent accomplishments and upcoming events.

MYOS RENS Technology Inc. (“MYOS” or “the Company”) (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, a proprietary bioactive composition derived from fertilized egg yolk that helps build lean muscle, announced today that it will provide financial results for the first quarter 2019 on Wednesday, May 8, 2019 after the market closes.

National architecture and engineering firm HED is pleased to announce its hiring of six senior level healthcare staff members in its Boston office.